TDRD5
gene geneOn this page
Also known as FLJ34823TUDOR3
Summary
TDRD5 (tudor domain containing 5, HGNC:20614) is a protein-coding gene on chromosome 1q25.2, encoding Tudor domain-containing protein 5 (Q8NAT2). Required during spermiogenesis to participate in the repression transposable elements and prevent their mobilization, which is essential for the germline integrity.
Predicted to be involved in P granule organization; spermatid development; and transposable element silencing by piRNA-mediated DNA methylation. Predicted to be located in chromatoid body and pi-body. Predicted to be active in synapse.
Source: NCBI Gene 163589 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 131 total
- MANE Select transcript:
NM_001199085
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20614 |
| Approved symbol | TDRD5 |
| Name | tudor domain containing 5 |
| Location | 1q25.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ34823, TUDOR3 |
| Ensembl gene | ENSG00000162782 |
| Ensembl biotype | protein_coding |
| OMIM | 617748 |
| Entrez | 163589 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 9 protein_coding
ENST00000294848, ENST00000367614, ENST00000417329, ENST00000444136, ENST00000897478, ENST00000897479, ENST00000897480, ENST00000897481, ENST00000918852
RefSeq mRNA: 6 — MANE Select: NM_001199085
NM_001199085, NM_001199089, NM_001199091, NM_001199092, NM_001349923, NM_173533
CCDS: CCDS1332, CCDS55663
Canonical transcript exons
ENST00000444136 — 18 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003713070 | 179591832 | 179592125 |
| ENSE00003888695 | 179621035 | 179621091 |
| ENSE00003890263 | 179595628 | 179595818 |
| ENSE00003890613 | 179634457 | 179634629 |
| ENSE00003891152 | 179690696 | 179691272 |
| ENSE00003891400 | 179662104 | 179662286 |
| ENSE00003892523 | 179639839 | 179640051 |
| ENSE00003892830 | 179652039 | 179652197 |
| ENSE00003893350 | 179630767 | 179630920 |
| ENSE00003893936 | 179635667 | 179635887 |
| ENSE00003894054 | 179654201 | 179654362 |
| ENSE00003894285 | 179593460 | 179593867 |
| ENSE00003894304 | 179618599 | 179618682 |
| ENSE00003894445 | 179650867 | 179651067 |
| ENSE00003894527 | 179663348 | 179663491 |
| ENSE00003895438 | 179640379 | 179640445 |
| ENSE00003895756 | 179592602 | 179592847 |
| ENSE00003895793 | 179669194 | 179669404 |
Expression profiles
Bgee: expression breadth ubiquitous, 126 present calls, max score 84.44.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2534 / max 57.2878, expressed in 127 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 6914 | 0.1401 | 82 |
| 6913 | 0.0671 | 37 |
| 6915 | 0.0462 | 21 |
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 84.44 | gold quality |
| left testis | UBERON:0004533 | 83.63 | gold quality |
| testis | UBERON:0000473 | 81.89 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.19 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 73.68 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 67.23 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 63.97 | gold quality |
| islet of Langerhans | UBERON:0000006 | 63.31 | gold quality |
| nucleus accumbens | UBERON:0001882 | 62.94 | gold quality |
| pituitary gland | UBERON:0000007 | 62.69 | gold quality |
| cortical plate | UBERON:0005343 | 62.63 | gold quality |
| adenohypophysis | UBERON:0002196 | 61.43 | gold quality |
| putamen | UBERON:0001874 | 60.30 | gold quality |
| caudate nucleus | UBERON:0001873 | 60.03 | gold quality |
| prefrontal cortex | UBERON:0000451 | 57.52 | gold quality |
| rectum | UBERON:0001052 | 57.16 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 56.46 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 56.43 | gold quality |
| pancreatic ductal cell | CL:0002079 | 55.93 | silver quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 55.75 | gold quality |
| thyroid gland | UBERON:0002046 | 55.52 | gold quality |
| hypothalamus | UBERON:0001898 | 54.97 | gold quality |
| adult organism | UBERON:0007023 | 54.76 | gold quality |
| metanephros cortex | UBERON:0010533 | 54.70 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 54.63 | gold quality |
| cortex of kidney | UBERON:0001225 | 54.58 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 54.16 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.05 |
| E-MTAB-8060 | no | 37.83 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
33 targeting TDRD5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-433-3P | 99.98 | 69.37 | 1203 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-9-3P | 99.96 | 70.88 | 2068 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-320A-3P | 99.77 | 69.73 | 2107 |
| HSA-MIR-320B | 99.77 | 69.73 | 2107 |
| HSA-MIR-320C | 99.77 | 69.73 | 2107 |
| HSA-MIR-320D | 99.77 | 69.73 | 2107 |
| HSA-MIR-4429 | 99.77 | 69.62 | 2111 |
| HSA-MIR-6885-3P | 99.75 | 70.36 | 3187 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-466 | 99.67 | 70.85 | 2863 |
| HSA-MIR-545-5P | 99.66 | 70.18 | 2308 |
| HSA-MIR-425-5P | 99.59 | 67.67 | 900 |
| HSA-MIR-12122 | 99.56 | 69.33 | 1672 |
| HSA-MIR-4643 | 99.49 | 67.63 | 1791 |
| HSA-MIR-520E-5P | 99.27 | 68.90 | 1513 |
| HSA-MIR-3973 | 99.20 | 69.19 | 1990 |
| HSA-MIR-9898 | 99.00 | 67.89 | 500 |
| HSA-MIR-361-5P | 98.95 | 70.16 | 1340 |
| HSA-MIR-374A-3P | 98.87 | 67.82 | 1531 |
| HSA-MIR-5094 | 98.63 | 67.11 | 1062 |
Literature-anchored findings (GeneRIF, showing 1)
- Here we evaluate gene and protein expression levels of four key TDRDs (TDRD1, TDRD5, TDRD9 and TDRD12) in testicular biopsy samples obtained from men with obstructive azoospermia (OA, n = 29), as controls, and various types of non-obstructive azoospermia containing hypospermatogenesis (HP, 28), maturation arrest (MA, n = 30), and Sertoli cell-only syndrome (SCOS, n = 32) as cases. (PMID:32059713)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tdrd5 | ENSMUSG00000060985 |
| rattus_norvegicus | Tdrd5 | ENSRNOG00000004018 |
| drosophila_melanogaster | qin | FBGN0263974 |
Paralogs (6): TDRD1 (ENSG00000095627), TDRD10 (ENSG00000163239), TDRD6 (ENSG00000180113), TDRKH (ENSG00000182134), TDRD7 (ENSG00000196116), TDRD15 (ENSG00000218819)
Protein
Protein identifiers
Tudor domain-containing protein 5 — Q8NAT2 (reviewed: Q8NAT2)
All UniProt accessions (3): A0A024R910, A0A0C4DG74, Q8NAT2
UniProt curated annotations — full annotation on UniProt →
Function. Required during spermiogenesis to participate in the repression transposable elements and prevent their mobilization, which is essential for the germline integrity. Probably acts via the piRNA metabolic process, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and govern the methylation and subsequent repression of transposons. Required for chromatoid body (CB) assembly.
Subcellular location. Cytoplasm.
Similarity. Belongs to the TDRD5 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8NAT2-3 | 3 | yes |
| Q8NAT2-1 | 1 |
RefSeq proteins (6): NP_001186014, NP_001186018, NP_001186020, NP_001186021, NP_001336852, NP_775804 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002999 | Tudor | Domain |
| IPR025605 | OST-HTH/LOTUS_dom | Domain |
| IPR035437 | SNase_OB-fold_sf | Homologous_superfamily |
| IPR037982 | TDRD5_LOTUS_2 | Domain |
| IPR041966 | LOTUS-like | Homologous_superfamily |
| IPR050621 | Tudor_domain_containing | Family |
Pfam: PF00567, PF12872
UniProt features (26 total): helix 5, domain 4, sequence variant 4, strand 3, compositionally biased region 3, region of interest 2, chain 1, modified residue 1, splice variant 1, sequence conflict 1, turn 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 3S93 | X-RAY DIFFRACTION | 2.28 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NAT2-F1 | 60.07 | 0.25 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 892
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 106 (showing top):
GOBP_AXIS_SPECIFICATION, TGCGCANK_UNKNOWN, GOBP_EMBRYONIC_AXIS_SPECIFICATION, GCANCTGNY_MYOD_Q6, GOBP_OOGENESIS, GOBP_MALE_GAMETE_GENERATION, FOXO1_01, EVI1_05, GOBP_ANATOMICAL_STRUCTURE_MATURATION, GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC, GOBP_DNA_METHYLATION_DEPENDENT_CONSTITUTIVE_HETEROCHROMATIN_FORMATION, GOBP_ANTERIOR_POSTERIOR_PATTERN_SPECIFICATION, GOBP_CELL_MATURATION, GOBP_EMBRYONIC_PATTERN_SPECIFICATION, RYTAAWNNNTGAY_UNKNOWN
GO Biological Process (6): spermatid development (GO:0007286), P granule organization (GO:0030719), transposable element silencing by piRNA-mediated DNA methylation (GO:0141196), germ cell development (GO:0007281), spermatogenesis (GO:0007283), cell differentiation (GO:0030154)
GO Molecular Function (0):
GO Cellular Component (4): chromatoid body (GO:0033391), synapse (GO:0045202), pi-body (GO:0071546), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| developmental process involved in reproduction | 2 |
| germ cell development | 1 |
| spermatid differentiation | 1 |
| organelle organization | 1 |
| pole plasm assembly | 1 |
| transposable element silencing by heterochromatin formation | 1 |
| gene silencing by piRNA-directed DNA methylation | 1 |
| gamete generation | 1 |
| cellular process involved in reproduction in multicellular organism | 1 |
| cell development | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| cytoplasmic ribonucleoprotein granule | 1 |
| cell junction | 1 |
| P granule | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
909 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TDRD5 | PIWIL1 | Q96J94 | 859 |
| TDRD5 | TDRD9 | Q8NDG6 | 847 |
| TDRD5 | PIWIL2 | Q8TC59 | 779 |
| TDRD5 | MARF1 | Q9Y4F3 | 755 |
| TDRD5 | PIWIL4 | Q7Z3Z4 | 741 |
| TDRD5 | MOV10L1 | Q9BXT6 | 703 |
| TDRD5 | TDRD12 | Q587J7 | 698 |
| TDRD5 | PLD6 | Q8N2A8 | 635 |
| TDRD5 | STK31 | Q9BXU1 | 624 |
| TDRD5 | MAEL | Q96JY0 | 608 |
| TDRD5 | NANOS3 | P60323 | 595 |
| TDRD5 | PNLDC1 | Q8NA58 | 593 |
| TDRD5 | PIWIL3 | Q7Z3Z3 | 560 |
| TDRD5 | FKBP6 | O75344 | 559 |
| TDRD5 | EXD1 | Q8NHP7 | 541 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TDRD5 | UBB | psi-mi:“MI:0914”(association) | 0.350 |
| GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (10): TDRD5 (Affinity Capture-MS), FABP5 (Affinity Capture-MS), PRSS3 (Affinity Capture-MS), TDRD5 (Affinity Capture-MS), UBB (Affinity Capture-MS), SRSF9 (Affinity Capture-MS), EIF4B (Affinity Capture-MS), TDRD5 (Affinity Capture-MS), MRPL27 (Cross-Linking-MS (XL-MS)), TDRD5 (Protein-RNA)
ESM2 similar proteins: A0JM98, A1L1H3, B7ZS37, D2H3M0, D3ZF42, E1BPH3, E2QTD3, F6YVB9, O75113, O88866, P62287, P62288, Q01804, Q13129, Q1L981, Q2T9I9, Q5H9M0, Q5HZN1, Q5QJC4, Q5SW75, Q5T5J6, Q5VCS6, Q5XIS7, Q5ZIX8, Q5ZKI7, Q5ZLE9, Q61194, Q63679, Q6A037, Q6DJS0, Q6GQJ2, Q6IE81, Q6IE82, Q6IFT4, Q6IVY4, Q6NRK3, Q6PCM1, Q6PJP8, Q6PUR7, Q6YI93
Diamond homologs: A0JM98, A1L1H3, A6NAF9, A6QLE1, B4F7C4, D2H0H6, D2H3M0, E1BPH3, E1C3S7, E2QTD3, E2RDV1, E7FDW8, Q1L981, Q5M7P8, Q5RAH6, Q5VCS6, Q6NU04, Q8K1H1, Q8NAT2, Q8NHU6, Q9R1R4, A9CPT4, H9JD76, Q1XG89, Q24180, Q3TPE9, Q58EK5, Q7M6Z3, Q80VL1, Q8R5A0, Q8VZG7, Q99MV1, Q9BXT4, Q9FLT0, Q9Y2W6, B5MCY1, Q4R3G4, Q99MV7, Q9BXT8, A4SG26
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
131 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 101 |
| Likely benign | 10 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3053 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:179593637:G:GG | donor_gain | 1.0000 |
| 1:179618594:CATA:C | acceptor_loss | 1.0000 |
| 1:179618595:ATAG:A | acceptor_loss | 1.0000 |
| 1:179618596:T:G | acceptor_gain | 1.0000 |
| 1:179618596:TAGC:T | acceptor_loss | 1.0000 |
| 1:179618597:A:AG | acceptor_gain | 1.0000 |
| 1:179618597:AGCT:A | acceptor_gain | 1.0000 |
| 1:179618598:G:A | acceptor_loss | 1.0000 |
| 1:179618598:G:GG | acceptor_gain | 1.0000 |
| 1:179618598:GCT:G | acceptor_gain | 1.0000 |
| 1:179618598:GCTG:G | acceptor_gain | 1.0000 |
| 1:179618674:A:G | donor_gain | 1.0000 |
| 1:179618678:AATTT:A | donor_gain | 1.0000 |
| 1:179618679:ATTT:A | donor_gain | 1.0000 |
| 1:179618680:TTT:T | donor_gain | 1.0000 |
| 1:179618681:TT:T | donor_gain | 1.0000 |
| 1:179618683:G:GG | donor_gain | 1.0000 |
| 1:179635666:GCAA:G | acceptor_gain | 1.0000 |
| 1:179639808:AT:A | acceptor_gain | 1.0000 |
| 1:179639822:ATTAT:A | acceptor_gain | 1.0000 |
| 1:179639826:T:TA | acceptor_gain | 1.0000 |
| 1:179640052:G:GG | donor_gain | 1.0000 |
| 1:179651081:G:GT | donor_gain | 1.0000 |
| 1:179652034:CTTA:C | acceptor_loss | 1.0000 |
| 1:179652035:TTAG:T | acceptor_loss | 1.0000 |
| 1:179652036:TA:T | acceptor_loss | 1.0000 |
| 1:179652037:A:AC | acceptor_loss | 1.0000 |
| 1:179652037:A:AG | acceptor_gain | 1.0000 |
| 1:179652037:AG:A | acceptor_gain | 1.0000 |
| 1:179652038:G:GT | acceptor_gain | 1.0000 |
AlphaMissense
6765 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:179635815:C:A | P483H | 0.999 |
| 1:179635823:T:C | F486L | 0.999 |
| 1:179635824:T:C | F486S | 0.999 |
| 1:179635825:C:A | F486L | 0.999 |
| 1:179635825:C:G | F486L | 0.999 |
| 1:179639939:T:A | W541R | 0.999 |
| 1:179639939:T:C | W541R | 0.999 |
| 1:179639942:T:A | W542R | 0.999 |
| 1:179639942:T:C | W542R | 0.999 |
| 1:179639948:C:G | R544G | 0.999 |
| 1:179640005:T:C | F563L | 0.999 |
| 1:179640007:T:A | F563L | 0.999 |
| 1:179640007:T:G | F563L | 0.999 |
| 1:179640009:G:A | G564E | 0.999 |
| 1:179640009:G:T | G564V | 0.999 |
| 1:179640418:T:G | C591W | 0.999 |
| 1:179650873:T:A | W603R | 0.999 |
| 1:179650873:T:C | W603R | 0.999 |
| 1:179650875:G:C | W603C | 0.999 |
| 1:179650875:G:T | W603C | 0.999 |
| 1:179650898:T:C | F611S | 0.999 |
| 1:179650973:T:C | L636S | 0.999 |
| 1:179592671:T:C | L19P | 0.998 |
| 1:179592782:T:C | L56P | 0.998 |
| 1:179593643:T:C | L139S | 0.998 |
| 1:179593708:T:C | F161L | 0.998 |
| 1:179593710:T:A | F161L | 0.998 |
| 1:179593710:T:G | F161L | 0.998 |
| 1:179593741:T:C | F172L | 0.998 |
| 1:179593743:T:A | F172L | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000007668 (1:179630552 C>T), RS1000016898 (1:179603303 A>G), RS1000065994 (1:179670602 C>A,T), RS1000084488 (1:179596389 G>A), RS1000090083 (1:179603587 C>T), RS1000130424 (1:179604998 G>T), RS1000176041 (1:179609725 C>G), RS1000181047 (1:179650139 G>A), RS1000184549 (1:179622125 T>C), RS1000306055 (1:179602862 T>C), RS1000351788 (1:179616489 A>G), RS1000426023 (1:179656206 G>T), RS1000451830 (1:179652348 A>G,T), RS1000486532 (1:179615725 A>G), RS1000486927 (1:179661334 T>C)
Disease associations
OMIM: gene MIM:617748 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006627_10 | Diastolic blood pressure | 1.000000e-10 |
| GCST009441_11 | Age-related cognitive decline (memory) (slope of z-scores) | 3.000000e-06 |
| GCST009441_14 | Age-related cognitive decline (memory) (slope of z-scores) | 2.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006336 | diastolic blood pressure |
| EFO:0007710 | cognitive decline measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression, affects expression, increases methylation | 6 |
| bisphenol A | decreases expression, decreases methylation | 2 |
| terbufos | increases methylation | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| Decitabine | affects expression | 1 |
| Benzo(a)pyrene | increases methylation, affects methylation | 1 |
| Cisplatin | affects expression | 1 |
| Fonofos | increases methylation | 1 |
| Estradiol | decreases expression | 1 |
| Parathion | increases methylation | 1 |
| Phthalic Acids | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.